David M. Knott’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.08M Hold
15,481
0.39% 52
2021
Q2
$1.07M Sell
15,481
-35,461
-70% -$2.37M 0.38% 53
2021
Q1
$3.29M Sell
50,942
-13,900
-21% -$896K 1.41% 19
2020
Q4
$3.78M Buy
64,842
+53,842
+489% +$3.25M 1.71% 13
2020
Q3
$695K Buy
+11,000
New +$763K 0.41% 42
2020
Q2
Sell
-1,500
Closed -$112K 96
2020
Q1
$112K Buy
+1,500
New +$104K 0.07% 83
2019
Q3
Sell
-3,500
Closed -$236K 121
2019
Q2
$236K Buy
+3,500
New +$230K 0.1% 71
2018
Q2
Sell
-8,901
Closed -$671K 112
2018
Q1
$671K Sell
8,901
-1,000
-10% -$79.5K 0.28% 49
2017
Q4
$709K Sell
9,901
-519
-5% -$39.4K 0.28% 45
2017
Q3
$844K Hold
10,420
0.36% 34
2017
Q2
$738K Buy
10,420
+3,700
+55% +$246K 0.31% 38
2017
Q1
$456K Buy
6,720
+1,550
+30% +$109K 0.22% 38
2016
Q4
$370K Hold
5,170
0.19% 38
2016
Q3
$409K Sell
5,170
-100
-2% -$8.12K 0.21% 33
2016
Q2
$440K Hold
5,270
0.1% 47
2016
Q1
$484K Buy
5,270
+2,300
+77% +$207K 0.13% 47
2015
Q4
$301K Buy
+2,970
New +$309K 0.08% 54

Other funds holding GILD

David M. Knott's GILD Position: Q3 2021 in Review

David M. Knott held its Gilead Sciences (GILD) position steady in Q3 2021 at 15,481 shares worth $1.08M. The position accounts for 0.39% of the portfolio, ranked #52.

David M. Knott first reported a position in GILD in Q4 2015 and has held it in 17 quarters since. The position peaked at $3.78M in Q4 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • David M. Knott held 15,481 shares of Gilead Sciences worth $1.08M as of Q3 2021.
  • David M. Knott left its Gilead Sciences share count unchanged in Q3 2021.
  • Gilead Sciences made up 0.39% of David M. Knott's portfolio in Q3 2021, its #52 holding.
  • David M. Knott first reported a position in Gilead Sciences in Q4 2015 and has held it in 17 quarters since.
  • David M. Knott's Gilead Sciences position peaked at $3.78M in Q4 2020.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.